Recombinant CLDN18.2 (Zolbetuximab Biosimilar) antibody

Catalog No. ABIN7598120

This anti-CLDN18.2 (Zolbetuximab Biosimilar) antibody is a Chimeric Chimeric antibody detecting CLDN18.2 (Zolbetuximab Biosimilar) in . Suitable for Human.

Quick Overview for Recombinant CLDN18.2 (Zolbetuximab Biosimilar) antibody (ABIN7598120)

Target: CLDN18.2 (Zolbetuximab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Chimeric

Clonality: Chimeric

Conjugate: This CLDN18.2 (Zolbetuximab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-CLDN18.2 (Zolbetuximab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Zolbetuximab Biosimilar Antibody

Specificity: Claudin-18, CLDN18

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 3.3 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for CLDN18.2 (Zolbetuximab Biosimilar)

Target: CLDN18.2 (Zolbetuximab Biosimilar)

Alternative Name: Zolbetuximab Biosimilar

Target Type: Biosimilar

Background: Claudin-18, CLDN18

UniProt: P56856

CAS-No: 1496553-00-4